Cerebras is not worth owning at about $90 billion in value on roughly $500 million of revenue. A post the author replies to adds that it has only two customers and argues investment banks are using retail investors for exit liquidity. x.com 

Cerebras is difficult for retail investors to understand, and management has not done a great job explaining its business since going public. It deserves more attention as the most direct AI IPO of 2026, but going long Cerebras is hard to justify when Nvidia can be owned instead. x.com 

Cerebras is now worth buying after its shares fell into the previously stated $60-$120 buying range. The earlier concern was an out-of-control valuation and providing liquidity to insiders at much higher prices; the shares shown are about $117. x.com 

Cerebras is absurdly valued at about $50 billion against roughly $865 million of full-year revenue and $194 million for the quarter. Overpriced listings like this will hurt young investors and push them to give up on stock investing. x.com 

Cerebras is a gamble, not a generational buying opportunity. It hasn't really proven anything yet and is burning cash, so by the time its technology is widely used it could be too late. It could become huge, but beating a behemoth like Nvidia takes more than good technology. x.com  x.com 

Cerebras looks attractive because the short report's two-year wafer-life thesis rests on unvalidated reliability assumptions, not representative failure data. Energy per useful token, lower warranty utilization and ordinary repair accounting also undercut its financial conclusions. OpenAI has integrated Cerebras into production; AMD and AWS have announced integrations, while Oracle plans 2027 availability for ultra-fast inference, adding commercial validation despite the report. x.com  x.com 

Cerebras at about a $100B market cap already prices in its execution upside aggressively, leaving downside risk. The bull case is real: it is a genuine new architecture in AI compute, with OpenAI's $20B+ contract plus Amazon Web Services, Meta, Perplexity, GSK, Mistral, Notion and AlphaSense diversifying it away from G42 in the UAE. But Nvidia's Vera Rubin ramp in the second half of 2026, a possible Nvidia absorption of Groq and the CUDA moat weigh on it. A position might make sense nearer $200. … Show more

Cerebras is a stock to avoid in a cash-out environment where companies, executives, employees and early investors are selling to buyers. Per a WSJ report cited by @wallstengine, Nvidia's AI chip business is over 400x larger than Cerebras and growing nearly as fast, yet Cerebras trades around 134x trailing revenue, more than 5x Nvidia's multiple. x.com 

Vicor's efficient delivery of key power modules is part of the case for Cerebras meeting and exceeding its 2028-29 numbers. As models improve, more security breaches and deployments should make Cerebras look increasingly like a cybersecurity play. Its revenue ramp looks constrained by capacity, not yet by demand. Bullish on Cerebras but cautious on the broader market, with no short-term earnings prediction. x.com  x.com  x.com  x.com 

Cerebras' bull case requires implausible growth: its hardware revenue rose only $146M from 2024 to 2025, so expecting $1.6B more in 2026 is laughable. @balmy_investor bets on $2B of 2026 hardware revenue and nearly $3B with cloud services, which would be 20x 2025 revenue at a $60B market cap. x.com